Global Hyaluronic Acid Based Dermal Fillers Market 2022-2028

December 2022 | 62 pages | ID: G5BAB196DA04EN
Gen Consulting Company

Abstracts

The global hyaluronic acid based dermal fillers market size is projected to grow by USD 2.1 billion from 2022 to 2028, registering a CAGR of 7 percent, according to a new report by Gen Consulting Company.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global hyaluronic acid based dermal fillers market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the hyaluronic acid based dermal fillers industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for hyaluronic acid based dermal fillers can be segmented by product: single-phase product, duplex product. The single-phase product segment held the largest revenue share in 2021. Hyaluronic acid based dermal fillers market is further segmented by application: wrinkle correction, lip augmentation, rhinoplasty, others. Among these, the wrinkle correction segment was accounted for the highest revenue generator in 2021. Based on region, the hyaluronic acid based dermal fillers market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America captured the largest share of the market in 2021.

Market Segmentation

By product: single-phase product, duplex product

By application: wrinkle correction, lip augmentation, rhinoplasty, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global hyaluronic acid based dermal fillers market with some of the key players being Allergan plc, Anika Therapeutics Inc., BioPlus Co., Ltd., Genzyme Corporation, LG Life Sciences Ltd., Merz Pharma GmbH & Co. KGaA, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global hyaluronic acid based dermal fillers market.
• To classify and forecast the global hyaluronic acid based dermal fillers market based on product, application, region.
• To identify drivers and challenges for the global hyaluronic acid based dermal fillers market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global hyaluronic acid based dermal fillers market.
• To identify and analyze the profile of leading players operating in the global hyaluronic acid based dermal fillers market.

Why Choose This Report

• Gain a reliable outlook of the global hyaluronic acid based dermal fillers market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Single-phase product
Duplex product

PART 6. MARKET BREAKDOWN BY APPLICATION

Wrinkle correction
Lip augmentation
Rhinoplasty
Others

PART 7. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 8. KEY COMPANIES

Allergan plc
Anika Therapeutics Inc.
BioPlus Co., Ltd.
Genzyme Corporation
LG Life Sciences Ltd.
Merz Pharma GmbH & Co. KGaA
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER